Kiniksa Pharmaceuticals International, plc
Asset & Liabilities Breakdown
Asset Breakdown FY2021
Total Assets: $232.8M
Liabilities Breakdown FY2021
Total Liabilities: $47.8M
Asset Breakdown
Total Assets: $232.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $122.5M | 52.6% |
| Accounts Receivable | $4.0M | 1.7% |
| Inventory | $3.7M | 1.6% |
| Property, Plant & Equipment | $2.8M | 1.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $19.3M | 8.3% |
| Other Assets | $80.6M | 34.6% |
Liabilities Breakdown
Total Liabilities: $47.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.9M | 3.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $45.9M | 96.1% |